Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Enoxaparin yields superior net clinical benefit to UFH in subjects undergoing PCI for STEMI

Sep. 17, 2010

Lundbeck and Argenta disclose promising preclinical data on MCH1 receptor antagonists

Sep. 17, 2010

RAAM-DHF trial finds eplerenone may benefit patients with diastolic heart failure

Sep. 17, 2010

PAF-R is potential target to treat psoriasis

Sep. 17, 2010

GSK presents new prostanoid DP1 receptor antagonists

Sep. 16, 2010

New fatty-acid amide hydrolase 1 inhibitor JNJ-40355003 has preclinical analgesic effects

Sep. 16, 2010

BT-061 improves psoriasis in double-blind trial

Sep. 16, 2010

Cypher sirolimus-eluting stent superior to Endeavor zotarolimus-eluting stent in phase III trial

Sep. 16, 2010

Clinical data support potential of rufinamide for neuropathic pain

Sep. 16, 2010

Promising phase Ib/IIa data on OBP-601 in HIV

Sep. 15, 2010

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...